SCHEMBL12467968

SCHEMBL12467968

NC(=O)c1nc(C2CCNCC2)c(Cc2ccccc2)c(F)c1F

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 2/20 0.44
▸ GABRG2 P18507 1/20 0.44
▸ GABRB3 P28472 1/20 0.44
▸ CCR2 P41597 3/20 0.40
▸ PARP1 P09874 5/20 0.40
▸ GABRB2 P47870 1/20 0.40
▸ PRMT5 O14744 1/20 0.37
▸ IKBKB O14920 1/20 0.36
▸ CHUK O15111 1/20 0.36
▸ HRH1 P35367 1/20 0.36
▸ PARP2 Q9UGN5 1/20 0.36
▸ PLAT P00750 1/20 0.36
▸ HTR1A P08908 2/20 0.36
▸ SLC6A2 P23975 2/20 0.36
▸ SLC6A4 P31645 2/20 0.36
▸ SLC6A3 Q01959 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12467974 0.83 GABRA1 (0.43) GABRA1GABRG2GABRB3CCR2PARP1
SCHEMBL526965 0.78 GABRA1 (0.44) GABRA1GABRG2GABRB3PARP1GABRB2
SCHEMBL8598701 0.71 GABRA1 (0.44) GABRA1GABRG2GABRB3PARP1GABRB2
SCHEMBL528021 0.70 HTR1A (0.42) GABRA1GABRG2GABRB3GABRB2PRMT5
SCHEMBL15647254 0.68 PARP1 (0.43) PARP1PRMT5IKBKBCHUKPARP2
SCHEMBL23111536 0.68 GABRA1 (0.49) GABRA1GABRG2GABRB3GABRB2HRH1
SCHEMBL20400460 0.66 IKBKB (0.46) GABRA1PARP1GABRB2IKBKBCHUK
SCHEMBL15647257 0.66 PRMT5 (0.42) GABRA1PARP1GABRB2PRMT5IKBKB
SCHEMBL3300081 0.66 GABRA1 (0.42) GABRA1GABRG2GABRB3PARP1GABRB2
SCHEMBL28945930 0.66 GABRA1 (0.42) GABRA1GABRG2GABRB3CCR2GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598483-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME Rigel Pharmaceuticals, Inc. (US) 2013-06-05 — — EP disclosed
WO-2012016217-A1 AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME RIGEL PHARMACEUTICALS, INC. (US) 2012-02-02 — — WO disclosed
Send feedback